Bristol-Myers Squibb has achieved an settlement to purchase the medical-stage biotech corporation MyoKardia for $thirteen.1 billion, or $225 for each...
Bristol-Myers Squibb has achieved an settlement to purchase the medical-stage biotech corporation MyoKardia for $thirteen.1 billion, or $225 for each...
WhatsApp us